Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team

What are you looking for?

  • Conference Roundup
  • Contact Lenses
  • Diagnostics
  • Glaucoma
  • Myopia
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Retina
  • Spotlight Series
The evolving role of the optometrist in nonsurgical cataract management
Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team
Home > HPG/HA eye drops outperform CMC/HA in early post-cataract dry eye relief
  • Ocular Surface Disease

HPG/HA eye drops outperform CMC/HA in early post-cataract dry eye relief

Kelsey Moroz

Hydroxypropyl guar (HPG)/hyaluronic acid (HA) and carboxymethylcellulose (CMC)/HA lubricant eye drops showed superior short-term improvement in corneal health (CFS scores) after 1 week compared to CMC/HA drops in patients with dry eye disease following cataract surgery, according to a study. However, both treatments were found to be equally effective and safe by the end of the 3-week period.

In prospective, open-label, assessor-masked, parallel, randomized controlled trial involving 70 patients who had undergone cataract surgery, participants were randomly assigned to receive either HPG/HA or CMC/HA eye drops in a 1:1 ratio. Each group applied 1-2 drops 4 times daily for 3 weeks. The study assessed the efficacy of these treatments by measuring changes from baseline in several key indicators: corneal fluorescein staining (CFS) score, Ocular Surface Disease Index score, Schirmer’s test score (without anesthesia), tear break-up time, and central corneal sensitivity. These evaluations were conducted at weeks 1 and 3.

The study found that the HPG/HA group showed significantly better improvement in CFS scores at the 1-week mark compared to the CMC/HA group (mean improvement of -1.0 vs -0.1, P = 0.039). By week 3, both groups had similar CFS scores (mean improvement of -1.6 vs -1.3, P = 0.552). No significant differences were observed between the 2 groups in other secondary outcomes at either time point.

Only 1 adverse event (ocular hypertension) was reported during the study, occurring in the HPG/HA group. This event was mild, considered unrelated to the treatment, and resolved within a week.

Reference
Sun CC, Chan YH, Huang PW, Chen NN. Evaluation of Two Artificial Tears Containing Hyaluronic Acid for Post Cataract Surgery Dry Eye Disease: A Randomized Controlled Trial. Ophthalmol Ther. 2024; doi: 10.1007/s40123-024-01015-9. Epub ahead of print. PMID: 39127813.

Share

Related Content

  • Ocular Surface Disease

Perceived stress may precede worsening dry eye symptoms in young adults

  • Ocular Surface Disease

Post-menopausal women show more severe evaporative dry eye disease

  • Ocular Surface Disease

Dry eye diagnostic practices remain inconsistent worldwide, survey finds

  • Ocular Surface Disease

Spotlight on VEVYE®

  • Ocular Surface Disease

Intervening early in dry eye disease: reducing patient cost and disease burden

  • Ocular Surface Disease

Consensus guidance helps identify misdiagnosed demodex blepharitis

Share

Advisory Board

Kaleb Abbott, OD, MS, FAAO

Clark Chang, OD

Jessica Haynes, OD, FAAO, FORS, Dipl ABO

Monica Kalia, OD

Cecelia Koetting, OD, FAAO, DipABO

Roya Attar, OD, MBA, DHA, FAAO

Hardeep Kataria, OD, FAAO

Marc R. Bloomenstein, OD, FAAO

Elise Kramer, OD

See All
Optometry 360

Optometry 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

© 2026 Optometry 360 is a trademark of International Healthcare Media, LLC. All rights Reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophthalmology360 Icon